MRVI Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık

03

Fiyat $7.90

P/E (TTM) -15.2

Hisse Başına Kâr (TTM) $-0.52

Gelir (TTM) $209M

ROE (TTM) -32.9%

D/E Borç/Özsermaye (MRQ) 0.7

52 Haftlık Aralık $3–$9

MRVI Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin

04

aralık

çubuklar

Çubuk çözünürlüğü seçilen döneme uyum sağlar — bir çubuk için açılış/yüksek/düşük/kapanış değerlerini görmek için grafiğin üzerine gelin.

Maravai LifeSciences Holdings, Inc. - Class A common stock Hakkında Wikipedia'dan şirket genel bakışı

05 · wikidata

Wikidata ↗

sektörHealthcare endüstriLife Sciences Tools & Services çalışanlar415 ülkeUS

10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri

06

Gelir$186M

2019-12-31 → 2025-12-31

Hisse Başına Kâr$-0.90

2019-12-31 → 2025-12-31

Serbest Nakit Akışı$-71M

2021-12-31 → 2025-12-31

Net kar marjı-37.1%

2021-12-31 → 2025-12-31

Değerleme ve Oranlar 07–12

Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?

Metrik	5 Yıllık trend	MRVI	5Y ort.	Akran Ortalaması	Sonuç
P/E (TTM)		-15.25Y ort. ≈-5.4	≈-5.4	·	·

Akran ortalaması, metrik başına standartlaştırılmış bir temelde hesaplanır ve bu hisse senedi için gösterilen TTM/MRQ temelini her zaman eşleşmeyebilir.

Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC

Metrik	MRVI	5Y ort.	Akran Ortalaması	Sonuç
Brüt Kar Marjı (TTM)	34.9%	·	50.6%	Zayıf
Faaliyet Kâr Marjı (TTM)	-56.1%5Y ort. ≈-72.6%	≈-72.6%	-0.30%	Zayıf
EBITDA Margin (FAVÖK Marjı)	-115.9%5Y ort. ≈-72.6%	≈-72.6%	-0.20%	Zayıf
Vergi Öncesi Kar Marjı (TTM)	-65.4%5Y ort. ≈-4.5%	≈-4.5%	0.17%	Zayıf
Net Kâr Marjı (TTM)	-37.1%5Y ort. ≈-55.8%	≈-55.8%	-1.1%	Zayıf
ROA (TTM)	-10.3%5Y ort. ≈-11.2%	≈-11.2%	-2.7%	Zayıf
ROE (TTM)	-32.9%5Y ort. ≈-38.9%	≈-38.9%	-3.3%	Zayıf
ROIC	-41.9%5Y ort. ≈-26.3%	≈-26.3%	-4.4%	Zayıf

Finansal Sağlık Borç, likidite, solventlik — bilanço gücü

Metrik	MRVI	5Y ort.	Akran Ortalaması	Sonuç
Borç / Öz Sermaye (MRQ)	0.75Y ort. ≈1.2	≈1.2	0.7	Aynı seviyede
Cari Oran (MRQ)	4.15Y ort. ≈7.4	≈7.4	3.4	Güçlü likidite
Quick Ratio (Cari Oran)	5.45Y ort. ≈6.3	≈6.3	2.3	Güçlü likidite
Uzun Vadeli Borç / Özkaynak (MRQ)	0.75Y ort. ≈1.2	≈1.2	0.7	Aynı seviyede

Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR

Metrik	MRVI	5Y ort.	Akran Ortalaması	Sonuç
Revenue YoY (Gelir Yıllık Bazda)	-28.3%5Y ort. ≈-35.3%	≈-35.3%	·	·
Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı)	-40.5%5Y ort. ≈-23.8%	≈-23.8%	·	·
Revenue CAGR 5Y (Gelir 5 Yıllık Bileşik Büyüme Oranı)	-8.2%	·	·	·

Hisse Başı Metrikler Hisse Başı Kâr, hisse başına defter değeri, hisse başına nakit akışı, hisse başına temettü

Metrik	MRVI	5Y ort.	Akran Ortalaması	Sonuç
EPS (Diluted) (Hisse Başına Kar (Seyreltilmiş))	$-0.905Y ort. ≈$-0.95	≈$-0.95	·	·
Revenue / Share (Hisse Başına Gelir)	$1.295Y ort. ≈$1.79	≈$1.79	·	·
Cash Flow / Share (Hisse Başına Nakit Akışı)	$-0.405Y ort. ≈$0.20	≈$0.20	·	·

Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı

Metrik	MRVI	5Y ort.	Akran Ortalaması	Sonuç
Asset Turnover (Aktif Devir Hızı)	0.25Y ort. ≈0.2	≈0.2	0.4	Zayıf
Inventory Turnover (Stok Devir Hızı)	3.45Y ort. ≈3.2	≈3.2	3.8	Aynı seviyede
Receivables Turnover (Alacak Devir Hızı)	5.85Y ort. ≈5.5	≈5.5	5.9	Aynı seviyede
Revenue / Employee (Çalışan Başına Gelir)	≈$447.6K	·	·	·

değer · ≈ 5Y ort. · sektör ortalaması · ortalamaya göre değerlendirme

Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi

14

Ort. Sürpriz 33.9%

Sonraki Rapor Kas 04, 2026

Dönem	Rapor	EPS Gerçek	EPS Tahmin	Sürpriz
30 Haziran 2026	Ağu 11, 2026	$-0.02	$-0.04	54.6%
31 Mart 2026	May 11, 2026	$0.01	$-0.05	120.8%
31 Aralık 2025		$-0.04	$-0.07	44.7%
30 Eylül 2025		$-0.08	$-0.08	4.0%
30 Haziran 2025		$-0.08	$-0.07	-10.7%
31 Mart 2025		$-0.08	$-0.07	-9.7%

Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı

15

Gelir Tablosu 18

Metrik	2025	2024	2023	2022	2021	2020	2019
Revenue	$186M	$259M	$289M	$883M	$799M	$284M	$143M
Cost of Revenue	$152M	$151M	$149M	$169M	$141M	$80M	$67M
Gross Profit	$34M	$108M	$140M	·	·	·	·
R&D Expense	$17M	$19M	$17M	$18M	$15M	$9M	$4M
SG&A Expense	$145M	$162M	$151M	$129M	$100M	$94M	$48M
Operating Expenses	$249M	$344M	$172M	$309M	$245M	$164M	$119M
Operating Income	$-215M	$-236M	$-32M	$574M	$555M	$120M	$24M
Interest Expense	·	·	$46M	$20M	$30M	$31M	$30M
Interest Income	$11M	$27M	$28M	$2M	$0	$0	·
Other Non-op	$-4M	$-2M	$-1M	$-358.0K	$279.0K	$126.0K	$118.0K
Pretax Income	$-235M	$-261M	$618M	$551M	$531M	$82M	$-6M
Income Tax	$-4M	$-2M	$756M	$61M	$62M	$3M	$-652.0K
Net Income	$-131M	$-145M	$-119M	$220M	$182M	$89M	$-4M
EPS (Basic)	$-0.90	$-1.05	$-0.90	$1.67	$1.59	$7.43	$-0.03
EPS (Diluted)	$-0.90	$-1.05	$-0.90	$1.67	$1.56	$2.36	$-0.03
Shares (Basic)	144,360,000	137,906,000	131,919,000	131,545,000	114,791,000	10,351,000	253,917,000
Shares (Diluted)	144,360,000	137,906,000	131,919,000	255,323,000	257,803,000	28,908,000	253,917,000
EBITDA	$-215M	$-236M	$-32M	$574M	$555M	·	·

Bilanço 25

Metrik	2025	2024	2023	2022	2021	2020	2019
Cash & Equivalents	$217M	$322M	$575M	$632M	$551M	$236M	·
Receivables	$25M	$39M	$55M	$139M	$118M	$51M	·
Inventory	$40M	$50M	$51M	$43M	$52M	$33M	·
Prepaid Expense	$13M	$18M	$19M	$26M	$20M	$11M	·
Current Assets	$296M	$429M	$700M	$848M	$740M	$332M	·
PP&E (Net)	$151M	$164M	$163M	$53M	$46M	$101M	·
Accum. Depreciation	$68M	$53M	$32M	$20M	$13M	$11M	·
Goodwill	$129M	$160M	$326M	$284M	$153M	$224M	·
Intangibles	$152M	$195M	$221M	$217M	$118M	$178M	·
Other Non-current Assets	$42M	$60M	$78M	$116M	$53M	$4M	·
Total Assets	$771M	$1.01B	$1.49B	$2.28B	$1.92B	$1.27B	·
Accounts Payable	$3M	$12M	·	$6M	$8M	$8M	·
Accrued Liabilities	$37M	$40M	$60M	$53M	$35M	$39M	·
Current Liabilities	$45M	$57M	$87M	$110M	$94M	$131M	·
Capital Leases	$34M	$41M	$48M	$52M	$41M	$56M	·
Deferred Tax	·	$11.0K	·	$0	$0	$9M	·
Other Non-current Liabilities	$36M	$52M	$59M	$69M	$41M	$2M	·
Total Liabilities	$398M	$431M	$698M	$1.38B	$1.37B	$1.12B	·
Long-term Debt	$292M	$296M	$524M	$527M	$531M	$535M	·
Total Debt	$292M	$296M	$524M	$527M	$531M	·	·
Paid-in Capital	$199M	$182M	$129M	$138M	$128M	$85M	·
Retained Earnings	$10M	$141M	$286M	$405M	$185M	$854.0K	·
AOCI	$524.0K	$0	·	·	$0	$-44.0K	·
Stockholders' Equity	$212M	$325M	$417M	$545M	$315M	$89M	·
Liabilities + Equity	$771M	$1.01B	$1.49B	$2.28B	$1.92B	$1.27B	·

Nakit Akışı 16

Metrik	2025	2024	2023	2022	2021	2020	2019
Stock-based Comp	$30M	$49M	$35M	$19M	$10M	$25M	$2M
Deferred Tax	$-20.0K	$11.0K	$755M	$42M	$47M	$-5M	$-1M
Amort. of Intangibles	$28M	$28M	$27M	$24M	$18M	$20M	$20M
Restructuring	$18M	$-1M	$6M	$0	$0	·	·
Operating Cash Flow	$-58M	$7M	$126M	$536M	$369M	$152M	$24M
CapEx	$13M	$30M	$66M	$17M	$15M	$25M	$17M
Investing Cash Flow	$-31M	$-24M	$-122M	$-268M	$106M	$6M	$-17M
Debt Issued	·	$953.0K	$0	$8M	$0	$609M	$0
Net Debt Issued	$-5M	$-233M	$-5M	$-5M	$-6M	·	·
Stock Repurchased	·	·	·	$0	$0	$34M	$0
Net Stock Activity	·	·	·	$0	$0	·	·
Financing Cash Flow	$-16M	$-236M	$-61M	$-187M	$-159M	$53M	$-4M
Net Change in Cash	$-106M	$-253M	$-57M	$81M	$315M	$211M	$3M
Taxes Paid	$-555.0K	$670.0K	$-3M	$23M	$22M	·	·
Free Cash Flow	$-71M	$-22M	$61M	$519M	$354M	·	·
Levered FCF	·	·	$71M	$501M	$327M	·	·

Kârlılık 8

Metrik	2025	2024	2023	2022	2021	2020	2019
Gross Margin	18.3%	·	·	·	·	·	·
Operating Margin	-115.9%	-90.9%	-10.9%	65.0%	69.4%	·	·
Net Margin	-70.4%	-55.9%	-41.2%	24.9%	22.8%	·	·
Pretax Margin	-126.5%	-100.9%	213.8%	62.5%	66.4%	·	·
EBITDA Margin	-115.9%	-90.9%	-10.9%	65.0%	69.4%	·	·
ROA	-14.7%	-12.7%	-6.3%	10.5%	11.4%	·	·
ROE	-48.6%	-43.2%	-24.8%	51.2%	90.1%	·	·
ROIC	-41.9%	-37.7%	0.75%	47.6%	58.0%	·	·

Likidite ve Solventlik 5

Metrik	2025	2024	2023	2022	2021	2020	2019
Current Ratio	6.6	7.5	8.0	7.7	7.9	·	·
Quick Ratio	5.4	6.3	7.2	7.0	7.1	·	·
Debt / Equity	1.4	0.9	1.3	1.0	1.7	·	·
LT Debt / Equity	1.3	0.9	1.2	1.0	1.7	·	·
Interest Coverage	·	·	-0.7	28.1	18.3	·	·

Verimlilik 3

Metrik	2025	2024	2023	2022	2021	2020	2019
Asset Turnover	0.2	0.2	0.2	0.4	0.5	·	·
Inventory Turnover	3.4	3.0	3.1	3.6	3.3	·	·
Receivables Turnover	5.8	7.7	3.0	6.9	9.5	·	·

Hisse Başına 3

Metrik	2025	2024	2023	2022	2021	2020	2019
Revenue / Share	$1.29	$1.88	$2.19	$3.46	$3.10	·	·
Cash Flow / Share	$-0.40	$0.05	$0.96	$2.10	$1.43	·	·
EPS (TTM)	$-0.90	$-1.05	$-0.90	$1.67	$1.56	$2.36	·

Büyüme Oranları 5

Metrik	2025	2024	2023	2022	2021	2020	2019
Revenue YoY	-28.3%	-10.3%	-67.3%	10.5%	181.3%	·	·
Revenue CAGR 3Y	-40.5%	-31.3%	0.57%	·	·	·	·
Revenue CAGR 5Y	-8.2%	·	·	·	·	·	·
EPS YoY	·	·	·	7.0%	-33.9%	·	·
Net Income YoY	·	·	·	21.0%	104.6%	·	·

Değerleme (TTM) 4

Metrik	2025	2024	2023	2022	2021	2020	2019
Revenue TTM	$186M	$259M	$289M	$883M	$799M	$284M	·
Net Income TTM	$-131M	$-145M	$-119M	$220M	$182M	$89M	·
P/E	-3.6	-5.2	-7.3	8.6	26.9	11.9	·
Earnings Yield	-27.7%	-19.3%	-13.7%	11.7%	3.7%	8.4%	·

Gelir Tablosu 18

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue	$51M	$66M	$50M	$42M	$47M	$47M	$57M	$69M	$69M	$64M	$74M	$67M	$69M	$79M	$205M	$191M
Cost of Revenue	$31M	$32M	$37M	$36M	$40M	$39M	$37M	$37M	$39M	$38M	$35M	$37M	$43M	$34M	$53M	$38M
Gross Profit	$21M	$34M	$13M	$6M	$8M	$8M	$19M	$32M	·	·	·	·	·	·	·	·
R&D Expense	$4M	$4M	$4M	$4M	$5M	$5M	$5M	$5M	$5M	$5M	$5M	$4M	$4M	$4M	$5M	$5M
SG&A Expense	$32M	$29M	$32M	$35M	$39M	$40M	$41M	$39M	$41M	$41M	$38M	$39M	$35M	$39M	$37M	$31M
Operating Expenses	$36M	$36M	$-7M	$47M	$74M	$57M	$-20M	$198M	$83M	$83M	$-67M	$82M	$81M	$76M	$95M	$74M
Operating Income	$-15M	$-2M	$-59M	$-41M	$-66M	$-49M	$-38M	$-166M	$-13M	$-19M	$-7M	$-15M	$-12M	$3M	$109M	$117M
Interest Expense	·	·	·	·	·	·	·	$14M	$12M	$11M	·	$12M	$7M	$12M	·	$3M
Interest Income	$1M	$2M	$2M	$3M	$3M	$3M	$6M	$7M	$7M	$7M	$7M	$7M	$7M	$6M	$2M	$0
Other Non-op	$-52.0K	$-494.0K	$-43.0K	$-71.0K	$-4M	$24.0K	$43.0K	$72.0K	$-3M	$106.0K	$49.0K	$66.0K	$-2M	$168.0K	$914.0K	$-4.0K
Pretax Income	$-22M	$-7M	$-63M	$-45M	$-74M	$-53M	$-46M	$-172M	$-21M	$-22M	$656M	$-21M	$-13M	$-5M	$96M	$114M
Income Tax	$-171.0K	$-151.0K	$6.0K	$-92.0K	$-4M	$162.0K	$-7.0K	$311.0K	$-2M	$271.0K	$766M	$-5M	$-1M	$-3M	$8M	$14M
Net Income	$-12M	$-4M	$-36M	$-26M	$-40M	$-30M	$-26M	$-97M	$-10M	$-12M	$-106M	$-6M	$-7M	$-67.0K	$38M	$44M
EPS (Basic)	$-0.08	$-0.02	$-0.24	$-0.18	$-0.27	$-0.21	$-0.21	$-0.68	$-0.07	$-0.09	$-0.80	$-0.05	$-0.05	$0.00	$0.28	$0.34
EPS (Diluted)	$-0.08	$-0.02	$-0.24	$-0.18	$-0.27	$-0.21	$-0.21	$-0.68	$-0.07	$-0.09	$-0.80	$-0.05	$-0.05	$0.00	$0.30	$0.34
Shares (Basic)	147,996,000	146,426,000	·	144,683,000	144,236,000	143,425,000	·	141,555,000	135,842,000	132,333,000	·	131,930,000	131,864,000	131,739,000	·	131,540,000
Shares (Diluted)	147,996,000	146,426,000	·	144,683,000	144,236,000	143,425,000	·	141,555,000	135,842,000	132,333,000	·	131,930,000	131,864,000	131,739,000	·	131,651,000
EBITDA	$-15M	$-2M	·	$-41M	$-66M	$-49M	·	$-169M	$-10M	$-19M	·	$-15M	$-12M	$3M	·	$117M

Bilanço 25

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Cash & Equivalents	$70M	$166M	$217M	$244M	$270M	$285M	$322M	$578M	$573M	$562M	·	$580M	$580M	$628M	·	$617M
Receivables	$31M	$33M	$25M	$23M	$28M	$28M	$39M	$29M	$39M	$37M	·	$46M	$49M	$56M	·	$114M
Inventory	$41M	$40M	$40M	$45M	$47M	$50M	$50M	$50M	$49M	$50M	·	$49M	$47M	$55M	·	$62M
Prepaid Expense	$13M	$12M	$13M	$14M	$15M	$13M	$18M	$22M	$17M	$17M	·	$23M	$23M	$26M	·	$23M
Current Assets	$156M	$252M	$296M	$326M	$360M	$376M	$429M	$679M	$685M	$668M	·	$701M	$699M	$766M	·	$836M
PP&E (Net)	·	·	$151M	·	·	·	$164M	·	·	·	·	·	·	·	·	$48M
Accum. Depreciation	·	·	$68M	·	·	·	$53M	·	·	·	·	·	·	·	·	·
Goodwill	$129M	$129M	$129M	$129M	$129M	$160M	$160M	$172M	$326M	$326M	·	$326M	$326M	$327M	·	$284M
Intangibles	$138M	$145M	$152M	$186M	$193M	$200M	$195M	$202M	$207M	$214M	·	$228M	$235M	$242M	·	$223M
Other Non-current Assets	$38M	$40M	$42M	$49M	$52M	$58M	$60M	$61M	$63M	$75M	·	$86M	$93M	$127M	·	$87M
Total Assets	$604M	$713M	$771M	$849M	$897M	$960M	$1.01B	$1.28B	$1.45B	$1.44B	·	$2.27B	$2.26B	$2.32B	·	$2.25B
Accounts Payable	$7M	$9M	$3M	$8M	$12M	$10M	$12M	·	·	·	·	·	·	$5M	·	$9M
Accrued Liabilities	$30M	$29M	$37M	$48M	$50M	$45M	$40M	$38M	$41M	$35M	·	$56M	$50M	$70M	·	$60M
Current Liabilities	$38M	$43M	$45M	$62M	$70M	$63M	$57M	$63M	$69M	$59M	·	$78M	$75M	$125M	·	$116M
Capital Leases	·	·	$34M	$36M	$38M	·	$41M	·	·	·	·	$50M	$52M	$54M	·	$44M
Deferred Tax	·	·	·	·	$2M	$2M	·	·	·	·	·	$7M	$9M	$9M	·	·
Other Non-current Liabilities	$34M	$36M	$36M	$38M	$38M	$44M	$52M	$54M	$54M	$59M	·	$65M	$63M	$66M	·	$58M
Total Liabilities	$248M	$344M	$398M	$417M	$429M	$429M	$431M	$665M	$671M	$667M	·	$1.38B	$1.37B	$1.41B	·	$1.41B
Long-term Debt	$147M	$241M	$292M	$293M	$294M	$295M	$296M	$522M	$523M	$523M	·	$525M	$526M	$527M	·	$528M
Total Debt	$147M	$241M	·	$293M	$294M	$295M	·	$522M	$523M	$523M	·	$525M	$526M	$527M	·	$528M
Paid-in Capital	$208M	$202M	$199M	$197M	$191M	$187M	$182M	$176M	$168M	$134M	·	$125M	$120M	$114M	·	$134M
Retained Earnings	$-6M	$6M	$10M	$46M	$71M	$111M	$141M	$167M	$266M	$274M	·	$392M	$398M	$405M	·	$367M
AOCI	$459.0K	$466.0K	$524.0K	$579.0K	$574.0K	$324.0K	$0	·	·	·	·	·	·	·	·	·
Stockholders' Equity	$205M	$212M	$212M	$245M	$266M	$301M	$325M	$345M	$437M	$411M	·	$519M	$521M	$522M	·	$504M
Liabilities + Equity	$604M	$713M	$771M	$849M	$897M	$960M	$1.01B	$1.28B	$1.45B	$1.44B	·	$2.27B	$2.26B	$2.32B	·	$2.25B

Nakit Akışı 14

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Stock-based Comp	$10M	$7M	$4M	$9M	$7M	$10M	$11M	$13M	$14M	$12M	$9M	$10M	$9M	$6M	$6M	$5M
Deferred Tax	·	·	·	·	·	·	$11.0K	$0	$0	$0	$765M	$-6M	$-3M	$-2M	$7M	$9M
Amort. of Intangibles	$6M	$6M	$7M	$7M	$7M	$7M	$7M	$7M	$7M	$7M	$7M	$7M	$7M	$7M	$6M	$6M
Restructuring	$-33.0K	$3M	$10M	$7M	$0	$0	$6.0K	$-4.0K	$-4.0K	$-1M	$6M	$0	$0	$0	·	·
Operating Cash Flow	$4M	$9M	$-23M	$-15M	$-10M	$-9M	$-15M	$13M	$17M	$-8M	$8M	$14M	$19M	$85M	$99M	$110M
CapEx	$370.0K	$4M	$2M	$3M	$3M	$5M	$6M	$9M	$10M	$6M	$17M	$16M	$25M	$8M	$6M	$6M
Investing Cash Flow	$-370.0K	$-4M	$-2M	$-3M	$-3M	$-23M	$-5M	$-9M	$-6M	$-4M	$-13M	$-16M	$-24M	$-70M	$-19M	$-6M
Debt Issued	·	·	·	·	·	·	·	·	·	·	·	$0	$0	$0	$0	$0
Net Debt Issued	·	$-51M	·	·	·	$-1M	·	·	·	$-1M	·	·	·	$-1M	·	·
Financing Cash Flow	$-99M	$-55M	$-2M	$-8M	$-2M	$-5M	$-236M	$809.0K	$228.0K	$-560.0K	$470.0K	$783.0K	$-43M	$-19M	$-66M	$-37M
Net Change in Cash	$-95M	$-51M	$-27M	$-26M	$-15M	$-37M	$-256M	$5M	$11M	$-13M	$-5M	$-571.0K	$-48M	$-4M	$15M	$67M
Taxes Paid	$0	$0	$6.0K	$-26.0K	$-674.0K	$139.0K	$26.0K	$267.0K	$180.0K	$197.0K	$90.0K	$-3M	$449.0K	$-521.0K	$3M	$6M
Free Cash Flow	·	$4M	·	·	·	$-15M	·	·	·	$-14M	·	·	·	$77M	·	·
Levered FCF	·	·	·	·	·	·	·	·	·	$-25M	·	·	·	$74M	·	·

Kârlılık 8

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Gross Margin	40.1%	51.2%	·	13.6%	·	·	·	·	·	·	·	·	·	·	·	·
Operating Margin	-29.3%	-3.3%	·	-98.6%	-139.8%	-104.9%	·	-259.4%	-13.0%	-29.4%	·	-23.1%	-16.9%	3.2%	·	61.1%
Net Margin	-24.1%	-5.7%	·	-61.4%	-83.5%	-63.9%	·	-151.9%	-10.3%	-18.8%	·	-9.7%	-9.5%	-0.08%	·	23.2%
Pretax Margin	-42.4%	-9.9%	·	-108.5%	-156.4%	-112.5%	·	-269.4%	-23.1%	-34.9%	·	-30.8%	-19.4%	-5.7%	·	59.5%
EBITDA Margin	-29.3%	-3.3%	·	-98.6%	-139.8%	-104.9%	·	-259.4%	-13.0%	-29.4%	·	-23.1%	-16.9%	3.2%	·	61.1%
ROA	-1.7%	-0.45%	·	-2.4%	-3.4%	-2.5%	·	-5.6%	-0.41%	-0.64%	·	-0.29%	-0.29%	0.00%	·	2.1%
ROE	-5.3%	-1.5%	·	-8.6%	-11.3%	-8.4%	·	-22.9%	-1.6%	-2.6%	·	-1.3%	-1.3%	-0.01%	·	11.0%
ROIC	-4.3%	-0.47%	·	-7.6%	-11.2%	-8.3%	·	-19.5%	-0.85%	-2.0%	·	-1.1%	-0.99%	0.07%	·	9.9%

Likidite ve Solventlik 5

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Current Ratio	4.1	5.9	·	5.3	5.2	6.0	·	10.7	10.0	11.3	·	9.0	9.3	6.1	·	7.2
Quick Ratio	2.6	4.7	·	4.3	4.3	5.0	·	9.6	8.9	10.1	·	8.0	8.4	5.5	·	6.3
Debt / Equity	0.7	1.1	·	1.2	1.1	1.0	·	1.5	1.2	1.3	·	1.0	1.0	1.0	·	1.0
LT Debt / Equity	0.7	1.1	·	1.2	1.1	1.0	·	1.5	1.2	1.3	·	1.0	1.0	1.0	·	1.0
Interest Coverage	·	·	·	·	·	·	·	-12.4	-0.8	-1.7	·	-1.3	-1.7	0.2	·	37.3

Verimlilik 3

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Asset Turnover	0.1	0.1	·	0.0	0.0	0.0	·	0.0	0.0	0.0	·	0.0	0.0	0.0	·	0.1
Inventory Turnover	0.7	0.7	·	0.8	0.8	0.8	·	0.7	0.8	0.7	·	0.7	0.8	0.6	·	0.6
Receivables Turnover	1.7	2.1	·	1.6	1.4	1.4	·	1.7	1.7	1.4	·	0.8	0.8	0.9	·	2.1

Hisse Başına 3

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue / Share	$0.35	$0.45	·	$0.29	$0.33	$0.33	·	$0.46	$0.54	$0.48	·	$0.51	$0.52	$0.60	·	$1.45
Cash Flow / Share	·	$0.06	·	·	·	$-0.07	·	·	·	$-0.06	·	·	·	$0.65	·	·
EPS (TTM)	$-0.52	$-0.71	·	$-0.87	$-1.37	$-1.17	·	$-1.64	$-1.01	$-0.99	·	$0.20	$0.59	$1.17	·	$1.81

Değerleme (TTM) 4

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue TTM	$209M	$205M	·	$192M	$220M	$242M	·	$277M	$275M	$274M	·	$420M	$544M	$718M	·	$907M
Net Income TTM	$-77M	$-105M	·	$-121M	$-193M	$-163M	·	$-225M	$-134M	$-131M	·	$25M	$75M	$153M	·	$238M
P/E	-12.0	-4.0	·	-3.3	-1.8	-1.9	·	-5.1	-7.1	-8.8	·	50.0	21.1	12.0	·	14.1
Earnings Yield	-8.3%	-25.1%	·	-30.3%	-56.9%	-52.9%	·	-19.7%	-14.1%	-11.4%	·	2.0%	4.8%	8.3%	·	7.1%

En son dönem solda · null değerler · olarak gösterilir

Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl

16

Metrik	2025-12-31	2024-12-31	2024-09-30	2024-06-30	2023-12-31
Gelir	$186M	$259M	·	·	$289M
Brüt Kâr Marjı %	18.3%	·	·	·	·
Faaliyet Kâr Marjı %	-115.9%	-90.9%	·	·	-10.9%
Net Gelir	$-131M	$-145M	·	·	$-119M
Seyreltilmiş Hisse Başı Kâr	$-0.90	$-1.05	·	·	$-0.90

Metrik	2025-12-31	2024-12-31	2024-09-30	2024-06-30	2023-12-31
Borç / Öz Sermaye	1.4	0.9	·	·	1.3
Cari Oran	6.6	7.5	·	·	8.0
Cari Oran	5.4	6.3	·	·	7.2

Metrik	2025-12-31	2024-12-31	2024-09-30	2024-06-30	2023-12-31
Serbest Nakit Akışı	$-71M	$-22M	·	·	$61M

Kurumsal Sahipler (13F) 197 dosya · $904.1M toplam · Tarih itibarıyla 30 Haziran 2026

17

Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.

Sahipler 197

Tutulan Değer $904.1M

Yeni pozisyonlar 45

Çıkan pozisyonlar 24

Kurumsal faaliyet — Q2 2026 ve önceki çeyrek

Yeni pozisyonlar	Çıkan pozisyonlar	Artırıldı	Azaldı	Net hisse senedi değişimi
45 (+16 önceki Ç'ye göre)	24 (+1 önceki Ç'ye göre)	56 (+2 önceki Ç'ye göre)	59 (+6 önceki Ç'ye göre)	+19.0M

Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.

Kurum	Değer	Hisse senetleri	% izlenen 13F'nin	Tür
GTCR LLC	$125.736.031	20.150.005	13,91%	Hisse senetleri
BlackRock, Inc.	$62.217.666	9.970.780	6,88%	Hisse senetleri
BRAIDWELL LP	$54.306.227	8.702.921	6,01%	Hisse senetleri
12 West Capital Management LP	$44.055.617	7.060.195	4,87%	Hisse senetleri
MILLENNIUM MANAGEMENT LLC	$40.611.293	6.508.220	4,49%	Hisse senetleri
VANGUARD CAPITAL MANAGEMENT LLC	$32.970.070	5.283.665	3,65%	Hisse senetleri
Ophir Asset Management Pty Ltd	$30.118.596	4.826.698	3,33%	Hisse senetleri
RENAISSANCE TECHNOLOGIES LLC	$28.744.504	4.606.491	3,18%	Hisse senetleri
DEUTSCHE BANK AG\	$26.862.744	4.304.927	2,97%	Hisse senetleri
VANGUARD GROUP INC	$23.291.216	7.166.528	2,58%	Hisse senetleri
First Eagle Investment Management, LLC	$22.908.831	3.671.287	2,53%	Hisse senetleri
GEODE CAPITAL MANAGEMENT, LLC	$19.538.266	3.130.258	2,16%	Hisse senetleri
STATE STREET CORP	$18.106.645	2.901.706	2,00%	Hisse senetleri
Nuveen, LLC	$17.831.299	2.857.580	1,97%	Hisse senetleri
JPMORGAN CHASE & CO	$16.572.842	2.593.559	1,83%	Hisse senetleri
TWO SIGMA INVESTMENTS, LP	$14.076.317	2.255.820	1,56%	Hisse senetleri
Monaco Asset Management SAM	$13.921.602	2.231.026	1,54%	Hisse senetleri
PRUDENTIAL FINANCIAL INC	$13.429.441	2.152.154	1,49%	Hisse senetleri
CITADEL ADVISORS LLC	$13.245.011	2.122.598	1,47%	Hisse senetleri
Point72 Asset Management, L.P.	$12.514.813	2.005.579	1,38%	Hisse senetleri
MORGAN STANLEY	$11.907.642	1.908.276	1,32%	Hisse senetleri
Philosophy Capital Management LLC	$11.856.000	1.900.000	1,31%	Hisse senetleri
TUDOR INVESTMENT CORP ET AL	$11.538.253	1.849.079	1,28%	Hisse senetleri
ROYCE & ASSOCIATES LP	$11.284.716	1.808.448	1,25%	Hisse senetleri
GENERAL AMERICAN INVESTORS CO INC	$10.709.044	1.716.193	1,18%	Hisse senetleri
Hillsdale Investment Management Inc.	$10.501.159	1.682.878	1,16%	Hisse senetleri
SYSTEMATIC FINANCIAL MANAGEMENT LP	$10.394.704	1.665.817	1,15%	Hisse senetleri
GOLDMAN SACHS GROUP INC	$10.241.693	1.641.297	1,13%	Hisse senetleri
Tejara Capital Ltd	$9.954.953	1.595.345	1,10%	Hisse senetleri
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP	$9.444.901	1.513.606	1,04%	Hisse senetleri
MARSHALL WACE, LLP	$9.182.019	1.471.477	1,02%	Hisse senetleri
DIMENSIONAL FUND ADVISORS LP	$8.497.695	1.361.558	0,94%	Hisse senetleri
ArrowMark Colorado Holdings LLC	$7.956.000	1.275.000	0,88%	Hisse senetleri
Point72 (DIFC) Ltd	$7.430.106	2.588.887	0,82%	Hisse senetleri
KENNEDY CAPITAL MANAGEMENT LLC	$6.910.045	1.107.379	0,76%	Hisse senetleri
VANGUARD PORTFOLIO MANAGEMENT LLC	$6.686.385	1.071.536	0,74%	Hisse senetleri
JACOBS LEVY EQUITY MANAGEMENT, INC	$6.417.085	1.028.379	0,71%	Hisse senetleri
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	$6.290.588	1.008.107	0,70%	Hisse senetleri
NORTHERN TRUST CORP	$6.242.247	1.000.360	0,69%	Hisse senetleri
First Pacific Advisors, LP	$5.521.670	884.883	0,61%	Hisse senetleri
VANGUARD FIDUCIARY TRUST CO	$5.136.263	823.119	0,57%	Hisse senetleri
BNP PARIBAS FINANCIAL MARKETS	$4.948.083	792.962	0,55%	Hisse senetleri
Verition Fund Management LLC	$4.853.085	777.738	0,54%	Hisse senetleri
Qube Research & Technologies Ltd	$4.670.309	748.447	0,52%	Hisse senetleri
Decker Retirement Planning Inc.	$3.849.337	616.881	0,43%	Hisse senetleri
Invesco Ltd.	$3.570.279	572.160	0,39%	Hisse senetleri
NORGES BANK	$3.540.576	567.400	0,39%	Hisse senetleri
BANK OF AMERICA CORP /DE/	$3.304.379	529.548	0,37%	Hisse senetleri
Cerity Partners LLC	$2.928.800	469.359	0,32%	Hisse senetleri
TWO SIGMA ADVISERS, LP	$2.849.275	876.700	0,32%	Hisse senetleri

Tüm 197 kurumsal sahibi göster →

Şirket yöneticileri 25 içeriden öğrenenler · 13 yöneticiler · 13 yönetim kurulu üyeleri

19

İçeriden Öğrenen	Rol	Son işlem	Sahip olunan hisse senetleri	Alımlar 12ay	Satışlar 12ay	Net 12ay
Bernd Brust	Chief Executive Officer	08 Eylül 2026 F	1.561.249	3	0	$1.511.699
William E. Martin III	Chief Executive Officer	17 Mart 2025 A	1.814.643	0	0	$0
Rajesh Asarpota	Chief Financial Officer	30 Eylül 2026 F	418.021	0	0	$0
Kevin Herde	Chief Financial Officer	15 Mayıs 2025 A	674.636	0	0	$0
Andrew Burch	Former President, Nucleic Acid Production	15 Ocak 2025 F	369.183	0	0	$0
Eric Tardif	President	19 Kasım 2020 A	·	0	0	$0
Brian Neel	Chief Operating Officer, Nucleic Acid Production	15 Şubat 2023 F	16.473	0	0	$0
Lisa Sellers	Chief Operating Officer, Protein Detection	24 Kasım 2020 P	18.888	0	0	$0
Kurt Oreshack	General Counsel	10 Haziran 2026 S	335.767	0	2	$-254.000
Christine Dolan	Executive Vice President & General Manager, Cygnus Technologies	15 Mayıs 2026 A	425.318	0	0	$0
Peter Michael Leddy	Chief Administrative Officer	15 Temmuz 2025 F	727.177	0	0	$0
Rebecca Buzzeo	Chief Commercial Officer	17 Mart 2025 A	606.791	0	0	$0
Carl Hull	Executive Chairman	11 Kasım 2024 P	175.000	0	0	$0
Gregory T Lucier	Yönetim kurulu üyesi	09 Haziran 2026 G	156.077	2	0	$368.544
Susannah Gray	Yönetim kurulu üyesi	26 Mayıs 2026 A	216.200	0	0	$0
Luke Joseph Marker	Yönetim kurulu üyesi	26 Mayıs 2026 A	184.348	0	0	$0
Sean Laurence Cunningham	Yönetim kurulu üyesi	26 Mayıs 2026 A	184.348	0	0	$0
John A Deford	Yönetim kurulu üyesi	26 Mayıs 2026 A	205.478	0	0	$0
Andrew R Eckert	Yönetim kurulu üyesi	26 Mayıs 2026 A	412.183	0	0	$0
Murali Prahalad	Yönetim kurulu üyesi	16 Haziran 2025 A	154.607	0	0	$0
Benjamin James Daverman	Yönetim kurulu üyesi	16 Haziran 2025 A	138.055	0	0	$0
Jessica Hopfield	Yönetim kurulu üyesi	16 Haziran 2025 A	199.907	0	0	$0
Anat Ashkenazi	Yönetim kurulu üyesi	23 Mayıs 2024 A	60.768	0	0	$0
Robert B Hance	Yönetim kurulu üyesi	19 Kasım 2021 A	26.123	0	0	$0
Constantine S Mihas	·	26 Mayıs 2026 A	184.348	0	0	$0

SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış

ETF sahipliği 19 ETF'ler tarafından tutuluyor

20

Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.

Fon	Ağırlık	Birimler	Tarih itibarıyla	Kaynak
IBBQ · Invesco Exchange-Traded Fund Trust …	0,07%	10.546 SH	01 Ekim 2026	Günlük
IBB · iShares Trust	0,05%	804.353 SH	11 Eylül 2026	Günlük
PRFZ · Invesco Exchange-Traded Fund Trust	0,05%	179.599 SH	02 Ekim 2026	Günlük
VTWV · VANGUARD SCOTTSDALE FUNDS	0,04%	98.331 SH	19 Ağustos 2026	Günlük
IWM · iShares Trust	0,03%	2.915.565 SH	11 Eylül 2026	Günlük
RSSL · Global X Funds	0,02%	53.877 NS	31 Temmuz 2026	N-PORT
VTWO · VANGUARD SCOTTSDALE FUNDS	0,02%	649.581 SH	19 Ağustos 2026	Günlük
DFAS · Dimensional ETF Trust	0,01%	285.768 NS	31 Temmuz 2026	N-PORT
VXF · VANGUARD INDEX FUNDS	0,01%	1.454.980 SH	19 Ağustos 2026	Günlük
VHT · VANGUARD WORLD FUND	0,01%	315.518 SH	19 Ağustos 2026	Günlük
WSML · iShares Trust	0,01%	7.056 SH	11 Eylül 2026	Günlük
DFSU · Dimensional ETF Trust	0,00%	8.779 NS	31 Temmuz 2026	N-PORT
DCOR · Dimensional ETF Trust	0,00%	10.921 NS	31 Temmuz 2026	N-PORT
ITOT · iShares Trust	0,00%	209.371 SH	11 Eylül 2026	Günlük
IWV · iShares Trust	0,00%	30.689 SH	10 Eylül 2026	Günlük
DFAC · Dimensional ETF Trust	0,00%	14.388 NS	31 Temmuz 2026	N-PORT
VTI · VANGUARD INDEX FUNDS	0,00%	3.706.103 SH	19 Ağustos 2026	Günlük
VTHR · VANGUARD SCOTTSDALE FUNDS	0,00%	8.106 SH	19 Ağustos 2026	Günlük
IWN · iShares Trust	·	1.068.761 SH	11 Eylül 2026	Günlük

MRVI Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel

21

derecelendirme · 15 analist AL

Medyan hedef $8.00 +1,3%

4 26,7% Güçlü Al

6 40,0% Al

5 33,3% Tut

0 0,0% Sat

0 0,0% Güçlü Sat

12 Aylık Fiyat Hedefi

5 analist · 2026-10-03

Ortalama hedef $7.60 -3,8%

Şimdi Mevcut fiyat $7.90

Düşük$7.00 Ortalama$7.60 Yüksek$8.00

Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı

22

Mali yıl bazında, fiyatlar her şirketin son mali yıl kapanışına göredir.

Hisse Sembolü	Piyasa Değeri	P/E	Gelir YoY	Net Kar Marjı	ROE	Brüt Kar Marjı
MRVI	·	-3.6	-28.3%	-70.4%	-48.6%	18.3%
BRKR	$7.17B	-314.1	2.1%	-0.25%	-0.40%	45.9%
SHC	$5.02B	65.3	5.7%	6.7%	14.0%	55.5%
ADPT	$2.50B	-41.6	54.8%	-21.5%	-28.2%	·
ALMR	·	·	·	·	·	·
FTRE	$1.61B	-1.6	1.0%	-36.2%	-171.1%	·
BLFS	·	-241.8	28.9%	·	·	·
PSNL	$816M	-8.7	-17.7%	-116.7%	-36.0%	·
AZTA	$1.32B	-23.5	3.5%	-9.4%	-3.3%	45.5%
CYRX	$479M	6.9	12.4%	44.4%	15.3%	47.1%

Son Haberler Bu şirketten bahseden son manşetler

23

Maravai (MRVI) 2026 Yılı 1. Çeyrek Kazanç Dökümü Yahoo Finance · 4 ay, 3 hafta önce

Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar

26

Sizin için önemli olan metrikleri seçin — Yukarıdaki Tam Temeller bölümündeki herhangi bir satırın yanındaki + işaretine tıklayın.

Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.

MRVI Sınıf A Maravai LifeSciences Holdings, Inc. - Class A common stock